Josh Waitzman
@jwaitz.bsky.social
Kidney doc, biochemist, and dad, taking life one kinesin-sized step at a time. He/him. Employed by Vertex Pharmaceuticals | BIDMC Nephrology | opinions my own
Tissue is the issue #nephjc
a pink box of soft tissues with flowers on it
ALT: a pink box of soft tissues with flowers on it
media.tenor.com
October 29, 2025 at 1:52 AM
Tissue is the issue #nephjc
2 years? I think we need a plan for a 2 week update!
Should we have continuously updated recs based on when new evidence comes out? I think NCCN cancer guidelines are like this
#nephjc
Should we have continuously updated recs based on when new evidence comes out? I think NCCN cancer guidelines are like this
#nephjc
October 29, 2025 at 1:51 AM
2 years? I think we need a plan for a 2 week update!
Should we have continuously updated recs based on when new evidence comes out? I think NCCN cancer guidelines are like this
#nephjc
Should we have continuously updated recs based on when new evidence comes out? I think NCCN cancer guidelines are like this
#nephjc
I have a hard time seeing how we progress from a smorgasbord of individually good therapies to a systematic approach as to which one(s) is (are) best for an individual patient
It’s a good problem but a problem nonetheless
#nephjc
It’s a good problem but a problem nonetheless
#nephjc
October 29, 2025 at 1:44 AM
I have a hard time seeing how we progress from a smorgasbord of individually good therapies to a systematic approach as to which one(s) is (are) best for an individual patient
It’s a good problem but a problem nonetheless
#nephjc
It’s a good problem but a problem nonetheless
#nephjc
I think it we need trials with bi-pronged approaches; it’s tough when no one company (until maybe recently) has therapies in both the immune-modulatory and general nephron preserving camps.
#nephjc
#nephjc
October 29, 2025 at 1:25 AM
I think it we need trials with bi-pronged approaches; it’s tough when no one company (until maybe recently) has therapies in both the immune-modulatory and general nephron preserving camps.
#nephjc
#nephjc
October 29, 2025 at 1:16 AM
Josh Waitzman—I work full-time for Vertex and part-time at BIDMC.
COI: Vertex has an ongoing trial of a BAFF/APRIL inhibitor.
Opinions are my own and I only know what’s public.
#nephjc
COI: Vertex has an ongoing trial of a BAFF/APRIL inhibitor.
Opinions are my own and I only know what’s public.
#nephjc
October 29, 2025 at 1:02 AM
Josh Waitzman—I work full-time for Vertex and part-time at BIDMC.
COI: Vertex has an ongoing trial of a BAFF/APRIL inhibitor.
Opinions are my own and I only know what’s public.
#nephjc
COI: Vertex has an ongoing trial of a BAFF/APRIL inhibitor.
Opinions are my own and I only know what’s public.
#nephjc
Stoners against kidney stones?
October 13, 2025 at 6:07 PM
Stoners against kidney stones?